Monod Bio
Seattle, US · Founded 2020 · Delaware corporation
Biotech
Founders & leadership
DA
Daniel Adriano Silva ManzanoExecutive Officer, Director
DM
Dave Melina JohnsonDirector
DM
David Melina ShoultzExecutive Officer, Director
AQ
Alfredo Quijano RubioExecutive Officer
BM
Berta Melina CimlerDirector
Reported raises · per SEC filings
Form D private placements▶$24.2MraisedJun 2022 · 31 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Alfredo A Quijano RubioExecutive Officer
- Daniel Adriano Silva ManzanoExecutive Officer, Director
- Karan A TakharDirector
- Dave Adriano JohnsonDirector
- Berta Melina CimlerDirector
- David A ShoultzExecutive Officer, Director
- Offering amount
- $26.3M
- Amount sold
- $24.2M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$6MraisedDec 2021 · 27 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Daniel Adriano Silva ManzanoExecutive Officer, Director
- Dave Melina JohnsonDirector
- David Melina ShoultzExecutive Officer, Director
- Alfredo Quijano RubioExecutive Officer
- Berta Melina CimlerDirector
- Offering amount
- $6.1M
- Amount sold
- $6M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.